Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-23, Stock:NVS, The news for the past five days is as follows:
2018-08-16: NEWS1: FDA Approves Teva’s Generic Version of EpiPen, Stock Up 7.5%.NEWS2: FDA approves first rival generic EpiPen, sending Teva shares up 6%.NEWS3: Mylan’s North America Sales Down 22% in Q2 2018: What’s Next?.NEWS4: MYL Stock Down ~3% since Its Q2 2018 Results on August 8.NEWS5: The Swiss Stock Market Climbed On Trade Deal Hopes.NEWS6: The Swiss Stock Market Climbed On Trade Deal Hopes.NEWS7: Analysts Cut Target Prices on MYL Stock after Its Q2 2018 Results.NEWS8: Market Morning: Gene Therapy Deregulation, Amazon to the Movies, SEC On Musk’s Tail.
2018-08-17: NEWS1: Merck, Eisai Get FDA Approval for Lenvima Label Expansion.NEWS2: Merck, Eisai Get FDA Approval for Lenvima Label Expansion.NEWS3: Mylan’s EpiPen Supply Shortages Continue: What to Expect Ahead.NEWS4: Array BioPharma Missed Sales Estimates for Q4 2018.NEWS5: Mylan’s Q2 Profit Fell against Backdrop of US Market Dynamics.NEWS6: The Swiss Stock Market Clung To A Small Gain.NEWS7: The Swiss Stock Market Clung To A Small Gain.NEWS8: ARAY Reports Record Revenue, PTIE Bleeds, EVOK To Face FDA In April.NEWS9: ARAY Reports Record Revenue, PTIE Bleeds, EVOK To Face FDA In April.
2018-08-20: NEWS1: LCI Whacked On Contract Loss, CWBR Awaits Data, Busy Months Ahead For PLSE.NEWS2: LCI Whacked On Contract Loss, CWBR Awaits Data, Busy Months Ahead For PLSE.NEWS3: Regeneron's Eylea Gets FDA Nod for Wet AMD as a 12-Week Dose.NEWS4: Regeneron's Eylea Gets FDA Nod for Wet AMD as a 12-Week Dose.NEWS5: Amgen Stock Up This Year So Far: Will the Rally Continue?.NEWS6: Amgen Stock Up This Year So Far: Will the Rally Continue?.NEWS7: Regeneron&apos;s Eylea Gets FDA Nod for Wet AMD as a 12-Week Dose.NEWS8: Novan Rallies On Positive Early Results For Inflammatory Skin Disease Medication.NEWS9: Mylan Cuts Its Fiscal 2018 Guidance, Citing US Market Challenges.NEWS10: Mylan Has a Strong Balance Sheet despite Weak Q2 Performance.NEWS11: The Swiss Stock Market Rose On Hopes For Trade Agreement.NEWS12: The Swiss Stock Market Rose On Hopes For Trade Agreement.NEWS13: Novan Announces Promising Clinical Results with SB414.
2018-08-21: NEWS1: GSK Reportedly Seeks Initial Bids For $4 Bln Indian Horlicks Unit.NEWS2: GSK Reportedly Seeks Initial Bids For $4 Bln Indian Horlicks Unit.NEWS3: Glaxo Stock Up This Year So Far: Will the Rally Continue?.NEWS4: Glaxo Stock Up This Year So Far: Will the Rally Continue?.NEWS5: Glaxo Stock Up This Year So Far: Will the Rally Continue?.NEWS6: The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows.NEWS7: The Swiss Stock Market Recovered From Early Weakness.NEWS8: The Swiss Stock Market Recovered From Early Weakness.NEWS9: Mylan Finds a Disconnect between Market View and Intrinsic Value.
2018-08-22: NEWS1: Incyte’s Revenue Stream in Q2 2018.NEWS2: Insight: Toxin at heart of drug recall shows holes in medical safety net.NEWS3: Toxin at heart of drug recall shows holes in medical safety net.NEWS4: The Swiss Stock Market Pulled Back In Cautious Trade.NEWS5: The Swiss Stock Market Pulled Back In Cautious Trade.

Answer: Decrease